GRI Bio Inc GRI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/06/24 EDT
0.4171quote price arrow up+0.0071 (+1.7417%)
Volume
55,658
52 week range
0.40 - 53.90
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.4171
  • 52 Week High53.90
  • 52 Week High Date05/08/23
  • 52 Week Low0.40
  • 52 Week Low Date05/03/24

Key Stats

  • Market Cap1.333M
  • Shares Out3.20M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta-1.63
  • YTD % Change-84.52

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.4171
  • 52 Week High53.90
  • 52 Week High Date05/08/23
  • 52 Week Low0.40
  • 52 Week Low Date05/03/24
  • Market Cap1.333M
  • Shares Out3.20M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta-1.63
  • YTD % Change-84.52

RATIOS/PROFITABILITY

  • EPS (TTM)-33.75
  • P/E (TTM)-0.01
  • Fwd P/E (NTM)-0.77
  • EBITDA (TTM)-11.384M
  • ROE (TTM)-1,002.46%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-4,822.00%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On GRI Bio Inc

 

Profile

MORE
GRI Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing, and commercializing therapies that target serious diseases associated with dysregulated immune responses leading to inflammatory, fibrotic, and autoimmune disorders. Its therapies are designed to target the activity of Natural Killer T (NKT) cells, which are key regulators earlier in the inflammatory cascade, to interrupt disease progression and restore the immune...
David Szekeres
Chairman of the Board
W. Marc Hertz Ph.D.
President, Chief Executive Officer, Director
Leanne Kelly
Chief Financial Officer
Address
2223 Avenida De La Playa, Suite 208
La Jolla, CA
92037
United States

Top Peers

SYMBOLLASTCHG%CHG
BBLG
Bone Biologics Corp
1.83-0.02-1.08%
ALLR
Allarity Therapeutics Inc
0.901-0.099-9.90%
NBSE
NeuBase Therapeutics Inc
0.4101+0.0051+1.2593%
EVLO
Evelo Biosciences Inc
0.0476+0.0041+9.4253%
PRFX
PainReform Ltd
0.84+0.019+2.3142%